SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-21-002034
Filing Date
2021-05-17
Accepted
2021-05-17 14:20:08
Documents
63
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cannapharmarx_10q-033121.htm 10-Q 453181
2 CERTIFICATION cannapharmarx_ex3101.htm EX-31.1 10706
3 CERTIFICATION cannapharmarx_ex3102.htm EX-31.2 10859
4 CERTIFICATION cannapharmarx_ex3200.htm EX-32 4945
  Complete submission text file 0001683168-21-002034.txt   3315517

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cpmd-20210331.xml EX-101.INS 459747
6 XBRL SCHEMA FILE cpmd-20210331.xsd EX-101.SCH 41822
7 XBRL CALCULATION FILE cpmd-20210331_cal.xml EX-101.CAL 55511
8 XBRL DEFINITION FILE cpmd-20210331_def.xml EX-101.DEF 198168
9 XBRL LABEL FILE cpmd-20210331_lab.xml EX-101.LAB 280702
10 XBRL PRESENTATION FILE cpmd-20210331_pre.xml EX-101.PRE 260377
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

IRS No.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27055 | Film No.: 21929481
SIC: 2834 Pharmaceutical Preparations